CLAUDINE WILLIAMSON: Open Payments
NPI 1548809916 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66 in 4 payments from 4 companies in 2025. Trend: 2023 $1,312 · 2024 $15 · 2025 $66
Food & beverage: $66
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
